We describe a method for the isolation of recombinant single-chain antibodies in a biologically active form. The single-chain antibodies are fused to a cellulose binding domain as a single-chain protein that accumulates as insoluble inclusion bodies upon expression in Escherichia coli. The inclusion bodies are then solubilized and denatured by an appropriate chaotropic solvent, then reversibly immobilized onto a cellulose matrix via specific interaction of the matrix with the cellulose binding domain (CBD) moiety. The efficient immobilization that minimizes the contact between folding protein molecules, thus preventing their aggregation, is facilitated by the robustness of the Clostridium thermocellum CBD we use. This CBD is unique in retaining its specific cellulose binding capability when solubilized in up to 6 M urea, while the proteins fused to it are fully denatured. Refolding of the fusion proteins is induced by reducing with time the concentration of the denaturing solvent while in contact with the cellulose matrix. The refolded singlechain antibodies in their native state are then recovered by releasing them from the cellulose matrix in high yield of 60% or better, which is threefold or higher than the yield obtained by using published refolding protocols to recover the same scFvs. The described method should have general applicability for the production of many protein-CBD fusions in which the fusion partner is insoluble upon expression.
ies, lymphokines, receptors, enzymes, and enzyme-inhibitors, have been produced from transformed host cells containing recombinant DNA. The host cells are transformed with an expression vector containing genes encoding the proteins of interest and then are cultured under conditions that favor the production of the desired protein.
Often, the heterologous protein produced by the host cells precipitates within the cell to form refractile (inclusion) bodies. For its isolation in the native (biologically active) state, the protein should be separated from cell debris, solubilized with a chaotropic agent such as high concentrations of urea or guanidinium hydrochloride, and then refolded by gradual removal of the denaturant (reviewed in 1). In cases in which the native state of the protein is dependent on the formation of intramolecular disulfide bonds, the protein is reduced while in the denatured state by addition of reducing agents (2) . The formation of disulfide bonds in the protein during the refolding process is initiated by the addition of oxidizing agents in the refolding buffer that is used during removal of denaturant from the denatured protein or subsequent to it.
Denaturation followed by refolding of recombinant proteins from inclusion bodies is frequently the only means by which the protein may be recovered in the native form. However, refolding is an empirical process that has to be optimized for each particular protein of interest (1) . Under conventional folding conditions, the yield of renaturation is often exceedingly low due to side reactions such as aggregation or formation of thermodynamically stable, but nonnative, folding intermediates. Furthermore, refolding should be performed at extremely low protein concentrations due to the kinetic competition between correct folding and incorrect aggregation (3) . Aggregation during refolding may be somewhat inhibited by the addition of cosolvents such as amino acids (arginine) or other salts or by refolding in the presence of molecular chaperones (4, 5) , but such remedies are inadequate, particularly for large industrial scale.
Aggregation during refolding may be prevented by immobilization of the denatured protein onto a solid phase prior to initiation of refolding. Some proteins may be charged under refolding conditions, so that they may be immobilized onto ion-exchange matrices in a low-ionic strength denaturant. Refolding is then induced by gradual removal of denaturant and release from the matrix by increasing the salt concentration (6) . This approach, while appropriate for charged proteins, is not adequate for proteins for which the net charge under pH conditions that are compatible with refolding is too small to allow efficient immobilization onto an ion-exchange matrix (as is the case with many single-chain antibodies, our unpublished observations). Furthermore, the protein may be immobilized by multiple interactions with the matrix, which may hinder its ability to fold properly. When immobilization of the denatured protein by itself is not an option, it is possible to engineer an affinity tag linked to the Nterminus or to the C-terminus of the protein. Small affinity tags, such as a hexahistidine tag, or a hexaarginine tag, were applied for such purposes. Histidine-tagged proteins may be immobilized and refolded on a metal-carrying support (7), while arginine-tagged proteins may be immobilized and refolded on a support carrying polyanionic groups (8) . One must assume that the folding of the immobilized protein is not perturbed by its proximity to the matrix and that placing a short tagging peptide at its terminus does not divert it into a nonproductive folding pathway.
Refolding of an immobilized protein with fewer physical constraints may be achieved by its immobilization through a polypeptide fusion partner. In folding of fusion proteins, when the individual fusion partners are joined by a flexible peptide linker, the fusion partners fold independent of each other (9) . However, most known protein tags (such as glutathione S-transferase, maltose-binding protein, staphylococcal protein A, and most bacterial and fungal cellulose and chitin-binding domains) will not be useful for the purpose of immobilization of a denatured fusion protein onto the appropriate affinity support. This is because the protein affinity tags themselves are not functional in the denatured state. A possible solution is to use as an affinity tag a protein whose compact and stable structure prevents it from unfolding under the conditions under which its fusion partner is completely denatured. Such proteins are rare, and one example, as discussed below, is the cellulose-binding domain from the Clostridium thermocellum cellulosome.
Cellulosomes are multienzyme complexes devoted to the efficient degradation of cellulose and hemicellulose by a highly specialized class of cellulolytic microorganisms (10) . The cellulosome in C. thermocellum comprises numerous subunits. Some, but not all, cellulases also have a distinct noncatalytic cellulose-binding domain (CBD). Fungal and bacterial CBDs appear to be different, the bacterial form being much larger (11) . The cellulase system of C. thermocellum contains both cellulosomal and noncellulosomal cellulases and xylanases. CBDs have recently been described for noncatalytic proteins, called scaffoldins (10) , which are responsible for the integration of enzyme subunits into the cellulosome complex. CBDs bind to, and can be eluted from, cellulose under mild conditions and specific reagents are not required. The CBDs retain their cellulose-binding properties when fused to heterologous proteins. They were proposed as affinity tags for protein purification and for enzyme immobilization (10, 11) . Other types of CBD fusion proteins have also been described for protein purification or enzyme immobilization purposes (11) (12) (13) (14) . Thus, CBDs appear as promising candidates for application as affinity tags for protein recovery through binding and elution from cellulose.
C. thermocellum CBD (a type IIIa clostridial CBD) has been cloned (15) , expressed, and purified from Escherichia coli (16) and its three-dimensional structure has been solved at high resolution (17) . A unique property of Clostridium thermocellum CBD is that it maintains its specific cellulose binding properties under conditions under which most proteins are denatured and nonfunctional. We found that this CBD, alone or when fused to single-chain antibodies, will bind reversibly to cellulose in up to 6 M urea. This property makes C. thermocellum CBD an ideal candidate for an affinity tag to be applied for matrix-assisted (in this case, cellulose-assisted) refolding of fusion proteins. When a protein-CBD fusion is denatured, allowed to bind cellulose, and then refolded, it is immobilized onto the cellulose matrix while the protein fused to CBD is still in the unfolded state. Gradual removal of the denaturant then facilitates the refolding of the protein into the native state. Finally, the refolded protein can be separated from the cellulose matrix by applying appropriate elution conditions. When necessary, the protein can be separated from CBD by proteolytic cleavage and chromatographic separation. In addition, after being refolded while bound to the cellulose matrix, the protein-CBD fusion may by recovered by digestion of the cellulose matrix by a cellulolytic enzyme (18) .
Recently we incorporated C. thermocellum CBD into a phage display system for efficient isolation of ligandbinding proteins, particularly single-chain antibodies, and for engineering the matrix-binding properties of CBD itself (19) . The modular design of our expression vectors makes it possible to proceed directly from isolation of the ligand-binding protein to its efficient production as described herein. Our examples are of the production of single-chain antibodies (scFvs)-CBD fusion proteins, many of which are notoriously difficult to refold by standard refolding protocols (20) .
MATERIALS AND METHODS

Construction of scFv-CBD Bacterial Expression Vectors
Initially we constructed vectors for phage display of scFv-CBD fusion proteins as described previously (19) . In those vectors, the C-terminus of the scFv was fused through a short tether composed of Ala-Ala-Ala-GlyGly to the N-terminus of the C. thermocellum CBD (GenBank Accession No. X68233). Next, we introduced by PCR the sequence encoding Asp-Tyr-Lys-Asp-AspAsp-Asp-Lys-Leu between the short tether to the Nterminus of the CBD cassette. This sequence comprises a FLAG epitope (21), followed by an enterokinase cleavage site. A complete expression cassette was then assembled by PCR and cloned into pET3d (Novagen, Madison, WI) for intracellular expression. A scheme of the constructed expression vector pFEKCA3d-scFv is shown in Fig. 1A . A second expression vector, pH6T-FEKCA3d-scFv (Fig. 1B) , was constructed by linking of the sequence encoding for Met-(His) 6 -Leu-Val-Pro-ArgGly-Ser to the 5Ј end of the scFv cassette of pFEKCA3d-scFv. When expressed from the latter plasmid the scFv-CBD fusion protein is preceded by a metal-binding His tag followed by the thrombin cleavage site. (Details regarding PCR primer sequences and PCR conditions are available upon request.) For bacterial expression, the plasmids were introduced into E. coli strain BL21(DE3) (Novagen), carrying the T7 RNA polymerase gene on its chromosome under the control of an IPTG-inducible lacUV5 promoter. yeast extract, 5 g/liter NaCl, supplemented with 1% glucose and 100 g/ml ampicillin) at 37°C. Protein expression was induced by addition of 1 mM IPTG for 3 h. Cells were harvested by centrifugation and the scFv-CBD fusion protein was isolated and purified as described below. Induction of pFEKCA3d-scFv-or pH6T-FEKCA3d-scFv-carrying cells resulted in the accumulation of the recombinant proteins as insoluble inclusion bodies.
Recovery of Inclusion Bodies
The bacterial paste (typically, 5 g from 500 ml of induced culture) was suspended in 70 ml of 50 mM Tris (HCl), pH 8.0/20 mM EDTA (TE 50:20) and lysed by addition of 20 mg lysozyme (Sigma) for 1 h at room temperature. Five milliliters of 5 M NaCl and 5 ml of 25% Triton X-100 (Sigma, Rehovot, Israel) were added and the cells were disrupted with a mechanical homogenizer (Tissumizer, Heidolph, Germany). The insoluble fraction of the disrupted cells was collected by centrifugation at 20,000g for 20 min at 4°C and was resuspended in TE 50:20 containing 1% Triton X-100. The insoluble fraction was collected again by centrifugation, resuspended in 40 ml of TE 50:20, and sedimented once more. The collected insoluble material was enriched in its scFv-CBD fraction, which accounted for 60 -80% of the inclusion body protein as judged by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). The inclusion bodies were solubilized in 8 M urea/TE 50:20 and reduced by addition of 50 mM 2,3,-dihydroxybutane-1,4-dithiol (DTE; Sigma, Israel). For complete solubilization and reduction, the inclusion bodies were left for 2 h at room temperature. The urea-insoluble material was removed by centrifugation at 22,000g for 10 min, and the urea-soluble protein was refolded as described below.
When the scFv-CBD fusion protein was made from pH6T-FEKCA3d-scFv, the urea-solubilized inclusion bodies were subjected to metal-chelate affinity chromatography on a Ni-NTA resin (Qiagen, Germany) as follows. EDTA was omitted from the washes, and the urea-solubilized inclusion bodies were loaded onto a Ni-NTA column. The column was washed with 10 column volumes of 8 M urea/50 mM Tris (HCl), pH 8.0/20 mM imidazole and eluted with 8 M urea/50 mM Tris (HCl), pH 8.0/250 mM EDTA. The eluted protein was then reduced by addition of 50 mM DTE prior to refolding.
Standard Refolding and Purification of scFv-CBD Fusion Proteins
The standard refolding protocol is a modification of the protocol described by Buchner et al. (2) , which is optimized for the refolding of single-chain antibodies and fusion proteins thereof. Refolding was initiated by rapid dilution of the solubilized and reduced inclusion bodies into 100 volumes of 20 mM Tris (HCl), pH 7.5/1 mM EDTA/250 mM NaCl (TBS) that was adjusted to pH 9.5 by addition of NaOH. Typically, 3.3 mg of inclusion bodies protein was diluted into 100 ml of TBS to a final protein concentration of 33 g/ml. The refolding solution was left at 4°C for 24 -72 h without stirring.
Following refolding, precipitates were removed by centrifugation at 22,000g for 20 min. The soluble refolded protein was adsorbed with 1 g of crystalline cellulose (Sigmacell 20; Sigma) for 1 h, and the cellulose was recovered by centrifugation. The cellulose pellet was washed twice with 40 ml of TBS adjusted to 1 M NaCl and once with 40 ml of distilled water. The bound scFv-CBD was eluted twice with 10 ml of 100 mM NaOH/100 mM NaCl, pH 13.0. The eluates were combined and neutralized to pH 7.5 by dialysis against 100 volumes of TBS at 4°C for 16 h. When required, the purified protein was concentrated using a Centricon microconcentrator (Amicon, Beverley, MA) with a 50,000-kDa cutoff. The purified protein was stored at Ϫ20°C.
Protein concentration of all fractions was determined by the Coomassie Plus Protein Assay Reagent (Pierce, Rockford, IL) using bovine serum albumin as a standard. Proteins were analyzed throughout by SDS-PAGE. Gels were stained with Coomassie brilliant blue.
Cellulose-Assisted Refolding and Purification of scFv-CBD Fusion Proteins
Cellulose-assisted refolding was carried out as follows: the solubilized reduced inclusion bodies were mixed with an equal volume of either 4 g/10 ml crystalline cellulose in TBS or 0.2 g/10 ml amorphous cellulose prepared by phosphoric-acid digestion of crystalline cellulose as described (18) . The suspension was stirred for 1 h at room temperature, to allow for binding to cellulose, and then transferred into dialysis tubes and dialyzed for 24 -72 h at 4°C against 100 volumes of TBS adjusted to pH 9.5 with NaOH.
Following refolding, the cellulose composite was recovered and washed twice with 40 ml of TBS adjusted to 1 M NaCl and once with 40 ml of distilled water. The cellulose-bound scFv-CBD was eluted twice with 10 ml of 100 mM NaOH/100 mM NaCl. The eluates were combined and neutralized by dialysis against 100 volumes of TBS at 4°C for 16 h. When required, the purified protein was concentrated using a Centricon microconcentrator (Amicon) with a 50,000-kDa cutoff. The purified protein was stored at Ϫ20°C.
Recovery of Purified scFv by Proteolytic Digestion While Immobilized
As an alternative to basic pH elution of scFv-CBD fusion proteins from cellulose, we liberated the scFv from the fusion protein by utilizing the enterokinase site we had engineered at the 3Ј end of the scFvs in the pFEKCA expression system (Fig. 1) . Here, the protein was subjected to proteolytic cleavage while immobilized onto the cellulose matrix. Typically, 20 g of scFv-CBD fusion protein was immobilized onto 2 mg of crystalline cellulose. The cellulose-bound protein was washed and equilibrated in 20 mM Tris (HCl), pH 7.4/50 mM NaCl/2 mM CaCl 2 . One unit of enterokinase light chain (New England Biolabs, Beverley, MA) was added and incubation was for 8 h at 23°C. The undigested and digested samples were analyzed by SDS-PAGE followed by immunoblotting, in which the undigested scFv-CBD and the free scFv were detected with an anti-FLAG monoclonal antibody, M2 (Eastman Kodak Co., New Haven, CT), recognizing the FLAG epitope at the 3Ј end of the scFv (Fig. 1) , followed with HRP-conjugated rabbit anti-mouse antibodies (Jackson Laboratories, West Grove, PA). The nitrocellulose filter was developed with the ECL Western blotting analysis system (Amersham, Buckinghamshire, England) as described by the vendor.
Analytical Gel-Filtration Chromatography
To assess the purity and aggregation status of the purified scFvs-CBD, aliquots were subjected to gelfiltration chromatography on a Superose 12 HR 10/30 column (Pharmacia, Sweden). TBS buffer was used to develop the column at 0.5 ml/min flow rate. The protein was monitored at 280 nm. Bio-Rad gel-filtration protein standards were used to calibrate the column.
Analysis of Antigen Binding by ELISA
To compare the immunoreactivity of the scFv-CBD proteins refolded under various conditions, their antigen binding properties were compared in an ELISA procedure. Antigen at 10 -20 g/ml in 50 mM NaHCO 3 buffer, pH 9.6, was coated onto 96-well ELISA plates for 16 h at 4°C. The plates were blocked with 2% skim milk powder in phosphate buffered saline (PBS), and all washes were with PBS containing 0.05% Tween 20 (Sigma). Serial dilutions of the analyzed scFv-CBD protein were added to the plates for a 1 h incubation at room temperature. The scFv-CBD bound to the antigen on the plate was detected with a rabbit polyclonal anti-CBD antiserum followed with HRP-conjugated goat anti-rabbit antibodies (Jackson Laboratories). The peroxidase substrate ABTS (Sigma) was used for development and the color was recorded at 405 nm.
RESULTS
Expression and Purification of the Anti-␤-amyloid Peptide scFv 508(Fv)-CBD Fusion
We isolated the scFv 508(Fv) from an antibodyphage display library using Alzheimer's ␤-amyloid peptide as a capturing antigen (in preparation). The 508(Fv) was cloned into pFEKCA3d (Fig. 1A) for expression. Upon IPTG induction of BL21(DE3) cells carrying pFEKCA3d-508(Fv), the overexpressed protein accumulated as insoluble inclusion bodies (Fig. 2, lane  3) . Five hundred milliliters of induced culture yielded 5.6 g of wet cell paste. Inclusion bodies were recovered from the bacterial paste, solubilized, and reduced as described under Materials and Methods. A total of 170 mg of wet inclusion bodies was recovered. The ureasoluble reduced inclusion bodies were 12 ml at 3.2 mg/ml (protein concentration), which was approximately 80% pure. One milliliter of solubilized reduced inclusion bodies (3 mg) was refolded by standard refolding. The rest (35 mg) was used in cellulose-assisted refolding on crystalline cellulose. Table 1 summarizes the protein quantities and production yield of 508(Fv)-CBD.
As shown in the Table 1 , for 508(Fv)-CBD the yield obtained by cellulose-assisted refolding was almost 20-fold that obtained by standard refolding. The SDS-PAGE analysis of the purification procedure is shown in Fig. 2 . Purification to Ͼ90% was achieved by cellu- lose-assisted refolding of 508(Fv)-CBD (lane 7). The protein obtained by standard refolding was of poor quality (mostly aggregated) and failed to bind antigen in an ELISA assay (not shown).
To assess the immunoreactivity of 508(Fv)-CBD prepared by cellulose-assisted refolding, binding of the purified protein was tested in ELISA. Similar quantities, with similar serial dilutions, were applied onto the ELISA plate that was coated with ␤-amyloid peptide and developed as described under Materials and Methods. The results are shown in Fig. 3 . From the ELISA analysis it is evident that 508(Fv)-CBD that was refolded on crystalline cellulose is active, as it binds ␤-amyloid peptide specifically compared to the Gal6(Fv)-CBD (an anti-␤-galactosidase scFv, see below) control. We produced a panel of three additional scFvs related to 508(Fv) that differ by point mutations at a single V L CDR3 position, by cellulose-assisted refolding. All were produced with comparable yields and had similar ␤-amyloid peptide binding properties in ELISA assays and eluted as monomer upon analytical gel-filtration analysis (not shown).
Expression and Purification of the ␤-GalactosidaseSpecific Gal6(Fv)-CBD Fusion
The scFv Gal6 specifically binds the E. coli enzyme ␤-galactosidase with high affinity (19) . Gal6(Fv) was cloned into pH6T-FEKCA3d (Fig. 1B) , and the resulting plasmid, pH6T-FEKCA3d-Gal6(Fv), was used for protein expression. Upon IPTG induction, Gal6(Fv)-CBD accumulated as insoluble inclusion bodies (Fig. 4,  lane 3) . Five hundred milliliters of induced culture yielded 5 g of wet cell paste.
The inclusion bodies were recovered from the bacterial paste and solubilized as described under Materials and Methods. A total of 1.3 g of wet inclusion bodies was recovered. The urea-soluble reduced inclusion bodies were 10 ml at 14 mg/ml (protein concentration), which was approximately 80% pure (Fig. 4, lane 3 . The solubilized inclusion bodies were loaded onto a Ni-NTA a The yield is calculated by the quantity of purified scFv-CBD as a percentage of the scFv-CBD amount in the inclusion bodies.
b Amount of urea-soluble inclusion bodies recovered from 5.6 g of wet bacterial paste from which 170 mg of wet inclusion bodies was obtained.
c Refolded-before purification of the standard refolded protein on cellulose.
d Refolded-the amount of protein immobilized on the cellulose matrix, calculated by subtracting the unbound protein and the protein in the washes from the quantity of inclusion body protein used in the cellulose-assisted refolding. column, washed, and eluted, which resulted in the enrichment of the scFv-CBD to Ͼ90% of the inclusion body protein (Fig. 4, lane 6 ). The inclusion bodies were then reduced and refolded.
One milliliter of solubilized reduced inclusion bodies (3.3 mg) was refolded by standard refolding. Two milliliters (6.6 mg) was used in cellulose-assisted refolding on either crystalline or amorphous cellulose. As shown in Table 2 , for Gal6(Fv)-CBD the yield obtained by cellulose-assisted refolding was about threefold more than that obtained by standard refolding. The SDS-PAGE analysis of the purification procedure is shown in Fig. 4 . Purification to Ͼ95% was obtained by all refolding methods (Fig. 4, lane 7 ; only the crystalline cellulose-assisted refolded protein is shown). In this case, the scFv-CBD fusion protein was almost pure before it was refolded, so in contrast to 508(Fv)-CBD for which cellulose-assisted refolding resulted also in further purification of the protein, here it served mostly to increase the refolding yield.
To test whether cellulose-assisted refolding yields monomeric protein, rather then aggregates, an aliquot of the crystalline-cellulose-assisted refolded Gal6(Fv)-CBD was subjected to analytical gel-filtration chromatography on a 25 ml Superose 12 column. As shown in Fig. 5A , the protein eluted from the column as a single major peak as expected for the scFv-CBD monomer. Analysis of the amorphous-cellulose-assisted refolded Gal6(Fv)-CBD by analytical gel filtration (Fig. 5B) showed that while most (ϳ70%) of the protein eluted from the column as a monomer, about 30% eluted as larger molecular forms, indicating the presence of aggregated protein in the preparation. Analysis of the standard refolded Gal6(Fv)-CBD by analytical gel filtration (Fig. 5C) showed that most of the protein was aggregated, while less than 40% eluted as a monomer. Thus, the actual quantitative advantage of celluloseassisted refolding of Gal6(Fv)-CBD is greater than the threefold difference shown in Table 2 .
To compare the immunoreactivity of Gal6(Fv)-CBD prepared by different refolding schemes, ␤-galactosidase binding by the purified proteins was tested in ELISA. Similar quantities, with similar serial dilutions were applied onto the ELISA plate that was developed as described under Materials and Methods. The results are shown in Fig. 6 , in which a celluloseassisted refolded anti-fluorescein antibody, 4-4-20(Fv)-CBD, served as a negative control. From the ELISA analysis it is evident that Gal6(Fv)-CBD that was refolded on crystalline cellulose is the most active, with the protein refolded on amorphous cellulose being somewhat less active and the standard refolded protein even less active. The reduced immunoreactivities of the amorphous cellulose-assisted refolded and of the standard refolded scFv-CBD are in agreement with the fraction of monomeric protein observed in the gel-filtration analysis (Fig. 5) . This indicates that celluloseassisted refolding using a crystalline cellulose matrix should be preferred. The concept behind matrix-assisted refolding in general is that by immobilizing the unfolded protein before refolding is initiated, loss of protein due to aggregation is minimized because the protein molecules are prevented from interacting with each other. The larger particle size of crystalline cellulose should perform better in that capacity than the fine fibers comprising amorphous cellulose.
To demonstrate the possibility of recovering purified Gal6(Fv) by proteolytic digestion, 20 g of Gal6(Fv)-CBD was immobilized onto crystalline cellulose. The immobilized fusion protein was treated with 1 unit of a The yield is calculated by the quantity of purified scFv-CBD as a percentage of the scFv-CBD amount in the inclusion bodies. Here the inclusion bodies were purified on Ni-NTA agarose before refolding.
b 15 mg of Ni-NTA-purified urea-soluble inclusion bodies recovered from 20 mg of urea-soluble inclusion bodies that was loaded on the column. In this experiment 5 g of wet bacterial paste yielded 1.3 g of wet inclusion bodies, from which 140 mg of urea-soluble inclusion bodies was recovered. Of these, a 20-mg aliquot was used in the subsequent steps.
enterokinase for 8 h and analyzed by immunoblotting as described under Materials and Methods. As shown in Fig. 6 , the undigested fusion protein was detected by the anti-FLAG monoclonal antibody M2 (lane 1), while in the digested sample, only the faster-migrating scFv band could be visualized. This indicates that digestion of the Gal6(Fv)-CBD fusion protein at the engineered enterokinase site, while immobilized on cellulose, could liberate the scFv completely. As shown in lane 3, the scFv can be separated from CBD by digestion in solution. This, however would make an additional separation step to remove CBD necessary.
DISCUSSION
In this study we have shown that recombinant fusion proteins comprising a single-chain Fv linked to C. thermocellum CBD can by refolded from E. coli-produced inclusion bodies in high yield. The refolding protocol is simple and based on cheap available materials. Scale-up should be feasible with little difficulty, and we have prepared batches of Ͼ50 mg purified proteins from 1-liter shake-flask cultures of several different scFvs. In all cases, the yields were at least 3-fold better than those obtained by standard refolding protocols. The specific binding activities were similar to those of the same scFv-CBD fusions that have been isolated from bacterial periplasmic fractions of cells carrying phage-display vectors (not shown). In all cases, 10-fold more scFv-CBD could be isolated from a similar culture volume by using intracellular expression and cellulose-assisted refolding compared to secretion.
Several methods for the isolation of refolded scFvs or fusion proteins thereof have been described (2, 20, (22) (23) (24) (25) . Our refolding method is based on the reagent system described in (2) with some modifications. In particular, and in striking difference from the published protocols, we can refold the protein at a high concentration. Most of the published refolding protocols are based on diluting the denatured protein to very low concentration (about 100 g/ml), to minimize aggregation. Since aggregation is prevented by immobilizing the denatured protein prior to denaturant removal, large quantities of protein can be handled using modest reagent volumes. This property is shared by other refolding methods relying on denatured protein immobilization (6 -8) . However, these methods (as our own) may not be suitable for any protein of interest. For example, eight different scFvs we had isolated in the lab do not bind ion-exchange resins, so the method described in (6) is not applicable for their production by refolding. Moreover, when we used the protocol for Ni-NTA-assisted refolding (7) for the isolation of Gal6(Fv)-CBD from pH6T-FEKCA3d, or from a construct in which Gal6(Fv) had a C-terminal His tag, the isolation yield was low. We could recover 20% or less of the material we loaded onto the resin in an active form. This may result from the proximity of the tag to the folding protein which may reduce the folding efficiency. In our case, the N-and C-termini of CBD are distal from the cellulose-binding planar strip (17) , so a protein linked to either terminus may be more free to refold.
In initial attempts to recover several scFv-CBD fusions by cellulose-assisted refolding, the proteins we recovered were not of sufficient purity. Apparently, the crystalline cellulose we used (Sigmacell 20) is not a highly selective matrix and binds other contaminating proteins in addition to the CBD fusion. Other available cellulose matrices for the isolation of CBD fusion proteins are commercially available (14) , some may perform better in the removal of contaminating proteins from the inclusion bodies. In our case, we could obtain refolded protein of satisfactory homogeneity only when the inclusion bodies were highly enriched in the scFv-CBD fusion protein (as was the case with 508(Ser)(Fv)-CBD; Fig. 2 ). Since there is a large batch-to-batch variability in the quality of the inclusion bodies (mostly dependent on the induction level, which varies for different scFvs), additional purification steps are required to recover a highly homogeneous protein preparation. Our solution for that problem was the addition of the His tag linked to the N-terminus of the fusion protein (Fig. 1B) . Thus it was possible to purify the protein in the denatured state on a Ni-NTA resin before it was refolded. Metal-chelate affinity chromatography is highly efficient as a single-step purification method (26, 27) , and in our case little additional purification was necessary after it was applied to enrich the scFv-CBD fraction in the inclusion bodies. When the scFv is liberated from CBD by specific proteolytic digestion (as shown in Fig. 7 ), the quality of the inclusion bodies is of lesser concern, as the contaminants are not liberated from the cellulose matrix under these conditions. On a larger scale, the protease will have to be removed after digestion is completed. The possibility of liberating the CBD fusion protein from the matrix is based on our experience with recovering the CBD-containing C. thermocellum cellulosome by affinity digestion (18) . A problem exists with the absence of commercially available purified cellulases that may serve this purpose. Since we believe that our method is of general applicability for the recovery of proteins other than single- chain antibodies, downstream purification steps can be designed based on the properties of the specific fusion partner.
Although our cellulose-assisted refolding method allows for refolding at high protein concentration, care should be taken not to overload the matrix with the CBD fusion protein. Under such conditions, unfolded protein monomers may interact to form multimers on the matrix, which will result in reduced active monomer recovery after refolding. An indication of such incidence is our experience with amorphous cellulose (Fig. 5) , of which we could use less to immobilize the protein, but the recovered material contained aggregated forms. The binding capacity of different cellulose matrices may vary, depending mostly on particle size and particle surface area. As a general rule, one should work well below the binding capacity of the matrix. For similar reasons, the binding of solubilized inclusion bodies to the cellulose matrix should be performed in batch, rather than on a column, to avoid "crowding" of the monomers that is expected to occur at the top of a column.
Finally, the elution conditions we apply to recover the refolded proteins from the cellulose matrix are rather harsh (100 mM NaOH, pH 13.0). Although the scFvs we have produced by this method tolerated the elution conditions, other fusion partners may be less tolerant of such conditions. Moreover, our refolded proteins may have been unfolded by the high pH and gradually refolded again during dialysis. Two observations make this unlikely in our case: first, several scFv-CBD fusions were efficiently recovered by immediate neutralization with Tris buffer following alkaline pH elution from cellulose rather than by gradual dialysis (not shown). Second, during dialysis the concentration of the eluted protein was quite high (about 0.25 mg/ml). Dialysis of unfolded scFv-CBD at that concentration results in loss of Ͼ80% of the protein due to aggregation. However, high pH elution may result in the unfolding of proteins. This difficulty should be overcome by reengineering the elution properties of CBD so that it may be recovered under milder conditions. For that purpose, we used rational design based on the CBD 3D structure (17) and the phage-display system for CBD (19) to identify CBD mutants having altered elution properties. One such mutant, having Asp56 and Trp118 both mutated to alanine, binds to cellulose with the same high capacity. However, its dissociation constant is increased about 20-fold. We incorporated this mutant CBD into our expression vectors described herein and found that the scFv-CBD fusion protein can be eluted by 0.01 M NaOH or 3% triethylamine. Such conditions are milder and acceptable for numerous protocols for the elution of proteins from affinity columns. In addition, scFv-CBD fusions with this mutant CBD are more efficiently recovered from cellulose, as over 95% of the cellulose-bound protein can be released under these conditions, while the recovery efficiency with wild-type CBD does not exceed 80% of bound protein. We are now in pursuit of additional CBD mutants with varying elution profiles (pH, ionic strength, etc.), which will not only broaden the applicability of our system for the recovery of a multitude of fusion partners, but will also serve as tools for efficient exploitation of cellulose binding domains in other avenues of biotechnology (10) .
